7Baggers
 If You Invested $1,000 in Verve Therapeutics, Inc. (VERV)  Stock Titan Sat, 04 Jul 2026 06:23:38 GMT
 verve therapeutics inc (verv) institutional confidence  TradingKey Wed, 17 Jun 2026 23:35:19 GMT
 one shot gene therapies spark pharma race  조선일보 Tue, 02 Jun 2026 07:00:00 GMT
 one shot gene therapies spark pharma race  조선일보 Mon, 01 Jun 2026 15:37:05 GMT
 Reporter’s Notebook: Are One-Shot Gene Editors Ready to Tackle Chronic Illness?  Inside Precision Medicine Mon, 01 Jun 2026 07:00:00 GMT
 big pharma turns to gene therapy after obesity treatments  조선일보 Mon, 01 Jun 2026 07:00:00 GMT
 | tctmd.com  TCTMD.com Mon, 01 Jun 2026 07:00:00 GMT
 big pharma eyes $80 billion gene therapy market  MSN Mon, 01 Jun 2026 06:19:05 GMT
 eli lilly (lly) reports positive phase 1b verve-102 study results  Yahoo Finance Fri, 29 May 2026 07:00:00 GMT
 a one-time experimental treatment might control cholesterol for life  Time Magazine Thu, 28 May 2026 07:00:00 GMT
 eli lilly (lly) reports positive phase 1b verve-102 study results  Yahoo Finance Thu, 28 May 2026 07:00:00 GMT
 promising gene editing therapy lowers ‘bad’ cholesterol  UCL | University College London Wed, 27 May 2026 07:00:00 GMT
 promising gene editing therapy lowers ‘bad’ cholesterol  UCL | University College London Tue, 26 May 2026 23:00:00 GMT
 Early data for heart drug affirm Lilly’s billion-dollar bet on Verve  BioPharma Dive Tue, 26 May 2026 07:00:00 GMT
 Lilly Plans Phase II For VERVE-102 Gene-Editing Therapy After Early LDL-C Data  insights.citeline.com Tue, 26 May 2026 07:00:00 GMT
 Verve Therapeutics gene editing therapy cuts LDL cholesterol by 62 percent  동아사이언스 Tue, 26 May 2026 07:00:00 GMT
 Lilly buys three vaccine makers; PCSK9 base editor shows promise  BioWorld News Tue, 26 May 2026 07:00:00 GMT
 Lilly’s one-shot cholesterol drug raises the stakes  The Pharma Letter Tue, 26 May 2026 07:00:00 GMT
 Eli Lilly's VERVE-102 Shows Promising Results in Early Trial  GuruFocus Tue, 26 May 2026 07:00:00 GMT
 can one treatment lower cholesterol and reduce heart attack risk for years?  Business Standard Tue, 26 May 2026 04:33:38 GMT
 In Vivo Base Editing of PCSK9 with VERVE-102 for Hypercholesterolemia  The New England Journal of Medicine Mon, 25 May 2026 07:00:00 GMT
 New data bolster Lilly's bet on Verve-developed PCSK9 editor  FirstWord Pharma Mon, 25 May 2026 07:00:00 GMT
 one-and-done heart disease prevention? scientists show it may be possible.  The New York Times Mon, 25 May 2026 07:00:00 GMT
 verve therapeutics : verv  24/7 Wall St. Mon, 18 May 2026 07:00:00 GMT
 three biotechs that are top takeover targets  24/7 Wall St. Mon, 18 May 2026 07:00:00 GMT
 in vivo gene editing market (2026-2035) | genetic engineering,  openPR.com Mon, 11 May 2026 07:10:07 GMT
 why verve therapeutics stock is skyrocketing today  msn.com Mon, 27 Apr 2026 11:57:12 GMT
 why verve therapeutics stock is skyrocketing today  MSN Sun, 26 Apr 2026 00:50:51 GMT
 why verve therapeutics stock is skyrocketing today  MSN Sat, 25 Apr 2026 23:25:44 GMT
 eli lilly buys verve therapeutics for 3x (f0n61nvgmx)  fathomjournal.org Thu, 23 Apr 2026 23:15:35 GMT
 lilly commits $7b to expand oncology footprint  eMarketer Tue, 21 Apr 2026 20:21:36 GMT
 why verve therapeutics stock is skyrocketing today  MSN Wed, 15 Apr 2026 15:55:17 GMT
 why verve therapeutics stock is skyrocketing today  MSN Tue, 14 Apr 2026 14:53:54 GMT
 hefh base editor shows promise in chinese clinical trial  Inside Precision Medicine Thu, 05 Mar 2026 11:56:13 GMT
 HeFH Base Editor Shows Promise in Chinese Clinical Trial  Inside Precision Medicine Tue, 03 Mar 2026 08:00:00 GMT
 verv deadline: verv investors have opportunity to lead verve the  GuruFocus Sun, 01 Mar 2026 18:05:52 GMT
 fda fleshes out new roadmap for testing personalized therapies  BioPharma Dive Mon, 23 Feb 2026 08:00:00 GMT
 eli lilly outlays $1.12bn for hearing loss gene therapy partnership  Pharmaceutical Technology Wed, 28 Jan 2026 08:00:00 GMT
 eli lilly partners with seamless in $1.12bn biotech pact  Latest news from Azerbaijan Wed, 28 Jan 2026 08:00:00 GMT
 lilly pens $1.1b pact to work on hearing loss gene editing med  Fierce Biotech Wed, 28 Jan 2026 08:00:00 GMT
 eli lilly signs deal with german company worth up to usd 1.12bn  medwatch.com Wed, 28 Jan 2026 08:00:00 GMT
 verve puts digital-first quality at the heart of its qc lab  Bioprocess Online Wed, 28 Jan 2026 00:48:39 GMT
 fda lifts hold on an intellia crispr drug trial  BioPharma Dive Tue, 27 Jan 2026 08:00:00 GMT
 Coming soon: First-in-human study of gene-modifying drug for hypercholesterolemia  Cardiovascular Business Fri, 23 Jan 2026 08:00:00 GMT
 the call events - 5th lnp formulation & process development summit  woonsocketcall.com Sun, 04 Jan 2026 03:21:16 GMT
 the call events - 5th lnp formulation & process development summit  woonsocketcall.com Sat, 03 Jan 2026 21:21:15 GMT
 healthcare and life sciences deal trends in 2025  Foley Hoag Mon, 22 Dec 2025 08:00:00 GMT

Verve Therapeutics
(NASDAQ:VERV) 

VERV stock logo

Verve Therapeutics, Inc, a clinical stage genetic medicines company, engages in developing gene editing medicines for patients to treat cardiovascular diseases in the United States.

Founded: 2018
CEO / Founder: Sekar Kathiresan 
Sector:
Industry:

Share this website to your friends